Sunday, June 20, 2021 1:33:11 PM
I'd guess that the scale of the value of a BO would be based on the total market value (plus annual estimated growth rate) vs the size of the potential estimated market for the device, and any new applications that would create new growth factors. And ENOS has much higher revenue potential than Mazer ($1.7B), or J&J with Auris ($3.4 & possibly another $2.3B) for comparison purposes.
Small $100M-$1.5B
Medium $1.6B-$10B
Large +$10B
In the scale of numbers, small compared to large is based on the spectrum from which you use to compare. Since we've seen many different buyout amounts, for various medical device company's as they would apply to each market - yours is small by comparison. IMO.
I live in Texas. We have different "local" scales.
Helen called. I told her you were out.
Good luck to all. Regards,BK.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM